<SEC-DOCUMENT>0001062993-19-002332-index.html : 20190517
<SEC-HEADER>0001062993-19-002332.hdr.sgml : 20190517
<ACCEPTANCE-DATETIME>20190517151352
ACCESSION NUMBER:		0001062993-19-002332
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190515
FILED AS OF DATE:		20190517
DATE AS OF CHANGE:		20190517

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gitman Paul
		CENTRAL INDEX KEY:			0001375378

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34236
		FILM NUMBER:		19835346

	MAIL ADDRESS:	
		STREET 1:		167 EXECUTIVE DRIVE
		CITY:			MANHASSET HILLS
		STATE:			NY
		ZIP:			11040

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOSPECIFICS TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0000875622
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				113054851
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		35 WILBUR ST
		CITY:			LYNBROOK
		STATE:			NY
		ZIP:			11563
		BUSINESS PHONE:		5165937000

	MAIL ADDRESS:	
		STREET 1:		35 WILBUR STREET
		CITY:			LYNBROOK
		STATE:			NY
		ZIP:			11563
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
<TEXT>
Document 1 - file: form4.html

Document 1 - RAW XML: form4.xml

</DOCUMENT>
</SEC-DOCUMENT>